These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates. Davydova M; Dewaele Le Roi G; Adumeau P; Zeglis BM J Vis Exp; 2019 Mar; (145):. PubMed ID: 30907883 [TBL] [Abstract][Full Text] [Related]
7. Improving the Stability of Maleimide-Thiol Conjugation for Drug Targeting. Lahnsteiner M; Kastner A; Mayr J; Roller A; Keppler BK; Kowol CR Chemistry; 2020 Dec; 26(68):15867-15870. PubMed ID: 32871016 [TBL] [Abstract][Full Text] [Related]
8. Stabilization of cysteine-linked antibody drug conjugates with N-aryl maleimides. Christie RJ; Fleming R; Bezabeh B; Woods R; Mao S; Harper J; Joseph A; Wang Q; Xu ZQ; Wu H; Gao C; Dimasi N J Control Release; 2015 Dec; 220(Pt B):660-70. PubMed ID: 26387744 [TBL] [Abstract][Full Text] [Related]
9. Highly homogeneous antibody modification through optimisation of the synthesis and conjugation of functionalised dibromopyridazinediones. Bahou C; Richards DA; Maruani A; Love EA; Javaid F; Caddick S; Baker JR; Chudasama V Org Biomol Chem; 2018 Feb; 16(8):1359-1366. PubMed ID: 29405223 [TBL] [Abstract][Full Text] [Related]
10. Cysteine-selective reactions for antibody conjugation. Cal PM; Bernardes GJ; Gois PM Angew Chem Int Ed Engl; 2014 Sep; 53(40):10585-7. PubMed ID: 25070879 [TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of β-galactosidase-sensitive antibody-drug conjugates. Kolodych S; Michel C; Delacroix S; Koniev O; Ehkirch A; Eberova J; Cianférani S; Renoux B; Krezel W; Poinot P; Muller CD; Papot S; Wagner A Eur J Med Chem; 2017 Dec; 142():376-382. PubMed ID: 28818506 [TBL] [Abstract][Full Text] [Related]
12. A dual-enzyme cleavable linker for antibody-drug conjugates. Bargh JD; Walsh SJ; Ashman N; Isidro-Llobet A; Carroll JS; Spring DR Chem Commun (Camb); 2021 Apr; 57(28):3457-3460. PubMed ID: 33687404 [TBL] [Abstract][Full Text] [Related]
13. Site-Specific Conjugation of Auristatins onto Engineered scFv Using Second Generation Maleimide to Target HER2-positive Breast Cancer in Vitro. Aubrey N; Allard-Vannier E; Martin C; Bryden F; Letast S; Colas C; Lakhrif Z; Collinet N; Dimier-Poisson I; Chourpa I; Viaud-Massuard MC; Joubert N Bioconjug Chem; 2018 Nov; 29(11):3516-3521. PubMed ID: 30352511 [TBL] [Abstract][Full Text] [Related]
14. Ahangarpour M; Kavianinia I; Hume PA; Harris PWR; Brimble MA J Am Chem Soc; 2022 Aug; 144(30):13652-13662. PubMed ID: 35858283 [TBL] [Abstract][Full Text] [Related]
15. Impact of Site-Specific Conjugation of ScFv to Multifunctional Nanomedicines Using Second Generation Maleimide. Hervé-Aubert K; Allard-Vannier E; Joubert N; Lakhrif Z; Alric C; Martin C; Viaud-Massuard MC; Dimier-Poisson I; Aubrey N; Chourpa I Bioconjug Chem; 2018 May; 29(5):1553-1559. PubMed ID: 29553717 [TBL] [Abstract][Full Text] [Related]
19. Generating site-specifically modified proteins via a versatile and stable nucleophilic carbon ligation. Kudirka R; Barfield RM; McFarland J; Albers AE; de Hart GW; Drake PM; Holder PG; Banas S; Jones LC; Garofalo AW; Rabuka D Chem Biol; 2015 Feb; 22(2):293-8. PubMed ID: 25619935 [TBL] [Abstract][Full Text] [Related]
20. Visible-Light-Induced Cysteine-Specific Bioconjugation: Biocompatible Thiol-Ene Click Chemistry. Choi H; Kim M; Jang J; Hong S Angew Chem Int Ed Engl; 2020 Dec; 59(50):22514-22522. PubMed ID: 32864829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]